PI3K blockade enhances the antitumor activity of eribulin in PIK3CA-mutant eribulin-resistant tumor xenografts Meeting Abstract


Authors: Serra, V.; Gris-Oliver, A.; Saura, C.; Oliveira, M.; Piris, A.; Ibrahim, Y. H.; Prudkin, L.; Pérez-Garcia, J. M.; Baselga, J.; Cortés, J.
Abstract Title: PI3K blockade enhances the antitumor activity of eribulin in PIK3CA-mutant eribulin-resistant tumor xenografts
Meeting Title: 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 73
Issue: 24 Suppl.
Meeting Dates: 2013 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2013-12-15
Language: English
ACCESSION: WOS:000209496902141
DOI: 10.1158/0008-5472.sabcs13-p5-08-06
PROVIDER: wos
Notes: Meeting Abstract: P5-08-06 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga